Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anaphylaxis
Pharma
Teva's Copaxone gets boxed warning for anaphylaxis risk
The warning also applies to generics, including Sandoz's Glatopa.
Zoey Becker
Jan 23, 2025 7:52am
ARS inks ex-US licensing pact for Neffy worth up to $465M
Nov 11, 2024 9:44am
FDA accepts ARS' filing for nasal spray EpiPen rival for review
Oct 25, 2022 10:27am
Bryn advances anaphylaxis spray after completing pivotal trial
Sep 19, 2022 7:00am
ARS inks reverse merger to get epinephrine nasal spray to market
Jul 26, 2022 10:22am
Oral rival to EpiPen clears test on path to pivotal trial
Apr 19, 2022 9:33am
